A $5.7 billion deal binds Intel to its struggling chip manufacturing business—revealing deeper U.S. strategic interests in domestic semiconductor control.
A Deal with Strings: Government Stake Tied to Foundry Control
Intel’s recent agreement with the Trump administration includes a strategic constraint: the company cannot spin off or sell its foundry business without facing financial penalties.
- Intel’s foundry unit, which builds chips for external customers, has long been unprofitable.
- Under the deal, the U.S. government receives a 10% equity stake in Intel.
- A five-year warrant allows the government to acquire another 5%—but only if Intel’s equity in its foundry business drops below 51%.
This structure effectively locks Intel in to retaining majority ownership of the unit for the foreseeable future.
Why the Government Cares About Intel’s Foundry
The U.S. government’s involvement is more than just financial—it’s strategic.
- The Biden administration (under policies continued from the Trump era) and the Trump campaign alike have emphasized the importance of domestic chip manufacturing.
- Taiwan Semiconductor Manufacturing Company (TSMC) dominates the global market, but its offshore operations pose a national security concern.
- The government wants critical chip-making capabilities rooted in U.S. soil, and Intel’s foundry unit plays a central role in this goal.
This explains the unusual deal structure: it discourages divestment of a key manufacturing asset even if the business is bleeding money.
Intel’s Loss-Making Foundry Unit: A Financial Burden
Despite its strategic value, the foundry unit is a drag on Intel’s bottom line.
- Intel Foundry reported a $3.1 billion operating loss in Q2 alone.
- Calls to spin out the unit have come from analysts, investors, and even board members.
- The plan to potentially offload the division seemed closer to reality last fall—until former CEO Pat Gelsinger, the unit’s chief advocate, retired suddenly in December.
By forcing Intel to hold onto this unit, the deal overrides investor pressure and limits Intel’s corporate flexibility.
A $5.7 Billion Cash Infusion Tied to the CHIPS Act
As part of the deal, Intel received a $5.7 billion cash injection—not new funding, but previous CHIPS Act grants finally disbursed.
- This is part of a broader public-private push to boost U.S. chip manufacturing.
- Intel’s CFO, David Zinsner, confirmed the cash landed last Wednesday.
- The warrant clause—designed to expire unused—serves more as a deterrent than a guarantee, effectively keeping Intel from pursuing a spinoff for at least five years.
A Tense Balance Between National Strategy and Corporate Survival
Intel’s situation highlights a growing tension: U.S. industrial policy may increasingly dictate corporate strategy.
- While the deal is protectionist, it aims to build resilience in America’s chip supply chain.
- Yet, it also forces a public company to hold onto a money-losing business against investor wishes.
- With the White House confirming the deal is still in progress, future revisions remain possible.
For now, Intel walks a tightrope—balancing patriotism, politics, and profit.
